Increased B-type Natriuretic Peptide (NT-proBNP) Level as a Risk Factor in Cardiosurgical Patients

Increased B-type Natriuretic Peptide (NT-proBNP) Level as a Risk Factor in Cardiosurgical Patients

Objective: to study the impact of increased inactive (N-terminal) pro-B-type natriuretic peptide (NT-proBNP) levels in cardiosurgical patients with coronary heart disease without drastically reducing left ventricular contractility on intraoperative central hemodynamics and the specific features of t...

Full description

Bibliographic Details
Main Authors:	I. A. Kozlov, I. Ye. Kharlamova
Format:	Article
Language:	English
Published:	Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia 2010-02-01
Series:	Общая реаниматология
Subjects:	b-type natriuretic peptides bnp nt-probnp coronary heart disease surgery under extracorporeal circulation.
Online Access:	https://www.reanimatology.com/rmt/article/view/505

Similar Items

Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP – A narrative review
by: Brian Kerr, et al.
Published: (2022-12-01)

Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
by: Chin-Shern Lau, et al.
Published: (2022-05-01)

RETRACTED: N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE (NT-proBNP) IN STAGE 1 AND STAGE 2 HYPERTENSION PATIENTS
by: Supriati Wila Djami
Published: (2019-10-01)

The Role of NT-proBNP Levels in the Diagnosis of Hypertensive Heart Disease
by: Angeliki Mouzarou, et al.
Published: (2025-01-01)

The Changes of Amino Terminal Pro B-type Natriuretic Peptide (NT-proBNP) Concentration and Left Ventricular Ejection Fraction on Doxorubicin Chemotherapy Patients
by: Telly Kamelia, et al.
Published: (2017-06-01)

Usefulness of NT-proBNP in dogs with heartworm: could this biomarker be useful to evaluate pulmonary hypertension?
by: Noelia Costa-Rodríguez, et al.
Published: (2023-08-01)

N-terminal prohormone brain natriuretic peptide (NT-proBNP) as a noninvasive marker for restrictive syndromes
by: C. Mady, et al.
Published: (2008-08-01)

NT‐proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme
by: Claire Sweeney, et al.
Published: (2021-12-01)

Correlation of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) with radiographic features of congestion in chest CT scan of patients with COVID-19
by: Naghmeh Ziaie, et al.
Published: (2023-07-01)

Influence of collaterals on the left ventricular end-diastolic pressure and serum NT-proBNP levels in patients with coronary chronic total occlusion
by: Fuad Samadov, et al.
Published: (2017-06-01)

Prognostic association of plasma NT-proBNP levels in patients with microvascular angina -A report from the international cohort study by COVADIS-
by: Akira Suda, et al.
Published: (2022-12-01)

The Role of NT-proBNP in the Diagnosis of Ventricular Arrhythmias in Patients with Systemic
by: Lucian MURESAN, et al.
Published: (2017-06-01)

NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population
by: Stefano Ciardullo, et al.
Published: (2022-11-01)

Optimal cut points of N-terminal of the prohormone brain natriuretic peptide (NT-proBNP) in patients with COVID-19
by: Mohammad Chehrazi, et al.
Published: (2022-03-01)

Analytical and clinical performance evaluation of a new NT-proBNP assay
by: Pingfeng Feng, et al.
Published: (2024-07-01)

ANALYSIS OF CHANGES IN THE SERUM LEVEL NT-proBNP AFTER ACE INHIBITORS THERAPY IN PATIENTS WITH HEART FAILURE
by: Halla Hisan Hartoto, et al.
Published: (2017-08-01)

Assessment of the Myocardial Stress Biomarker NT-proBNP in Real Clinical Practice
by: I. A. Kozlov, et al.
Published: (2023-02-01)

The effects of central arterial pressure and autonomic dysfunction on elevations in N-terminal pro-B-type natriuretic peptide (NT-proBNP) in men with diabetes
by: S. Bunce, et al.
Published: (2008-04-01)

The Perioperative Changes in and Clinical Value of B-type Natriuretic Peptide Levels in the Blood of Cardiosurgical Patients
by: I. A. Kozlov, et al.
Published: (2012-08-01)

NT‐proBNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure
by: Isaac R. Whitman, et al.
Published: (2019-04-01)

Setting the optimal threshold of NT‐proBNP and BNP for the diagnosis of heart failure in patients over 75 years
by: Emmanuelle Berthelot, et al.
Published: (2024-10-01)

Electrochemical Immunosensor for NT-proBNP Detection in Artificial Human Saliva: Heart Failure Biomedical Application
by: Elkahina Ghedir, et al.
Published: (2018-12-01)

Relationship between renalase and N-terminal pro-B-type Natriuretic Peptide (NT pro-BNP) in haemodialysis patients
by: Marcin Dziedzic, et al.
Published: (2014-03-01)

N-terminal-pro-brain natriuretic peptide, but not brain natriuretic peptide, is increased in patients with severe obesity
by: F. Fernandes, et al.
Published: (2007-02-01)

NT-proBNP AN IMPORTANT MARKER IN THE DIAGNOSTIC ALGORITHM IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND HEART FAILURE
by: Olga Bernaz, et al.
Published: (2024-05-01)

NT-proBNP AN IMPORTANT MARKER IN THE DIAGNOSTIC ALGORITHM IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND HEART FAILURE
by: Olga Bernaz, et al.
Published: (2024-05-01)

Prognostic value of the combination of uric acid and NT-proBNP in patients with chronic heart failure
by: Gülsüm Meral Yılmaz Öztekin, et al.
Published: (2022-05-01)

LSPR-Based Aptasensor for Rapid Urinary Detection of NT-proBNP
by: Maria António, et al.
Published: (2023-07-01)

Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors
by: Hussein Alawieh, et al.
Published: (2019-11-01)

Diagnostic value of NT–PRO BNP in cardiogenic and non cardiogenic pleural effusions
by: Mohamed E. Abdalla, et al.
Published: (2012-07-01)

Evaluation of in-Hospital NT-ProBNP Changes in Heart Failure Patients to Identify the Six-Month Clinical Response Following Cardiac Resynchronization Therapy
by: Gholamreza Davoodi, et al.
Published: (2014-01-01)

Prognostic and diagnostic significance of the cardiac biomarker NT-proBNP in the perioperative period of vascular surgery procedures
by: I. A. Kozlov, et al.
Published: (2023-10-01)

Correlation of NT-proBNP levels with clinical and echocardiographic features in evaluation of patients admitted with heart failure
by: Dhinakaran K, et al.
Published: (2023-12-01)

Association of Cancer with Heart Failure and the Prognostic Value of NT-proBNP in Cancer Patients: Findings from the NHANES (1999–2018)
by: Qingping Zeng, et al.
Published: (2024-08-01)

NT-proBNP Concentrations in the Umbilical Cord and Serum of Term Neonates: A Systematic Review and Meta-Analysis
by: Evangelos Christou, et al.
Published: (2022-06-01)

Development of a Rapid Diagnostic Kit for Congestive Heart Failure Using Recombinant NT-proBNP Antigen
by: Young-Ki Lee, et al.
Published: (2021-07-01)

Plasma N-terminal pro-B-type natriuretic peptide and urinary aldosterone-to-creatinine ratio in healthy Chihuahuas
by: Alberto Galizzi, et al.
Published: (2024-11-01)

Changes in Cardiac Levels of Caspase-8, Bcl-2 and NT-proBNP Following 4 Weeks of Aerobic Exercise in Diabetic Rats
by: Saeid Tanoorsaz, et al.
Published: (2017-12-01)

Serum brain natriuretic peptide (BNP) and N-terminal brain natriuretic peptide (NT-proBNP) in heart valve disease
by: J.A. Moolman, et al.
Published: (2017-04-01)

Paper Biosensor for the Detection of NT-proBNP Using Silver Nanodisks as Electrochemical Labels
by: Yi Peng, et al.
Published: (2022-06-01)